Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Part D Brand Discounts May Be More Useful In Catastrophic Phase, House Panel Told

Apr 30 2019

• By Cathy Kelly

pharmacist-discount-drugs

Related Content

Humana Jumps In: Medicare Part B Step Therapy Program Includes Cancer Drugs

Jan 30 2019

The Return Of The “Specialty” Drug Pricing Debate In The US

Apr 11 2019

Rebate Reshuffle: Could Pharma Foot The Bill To Offset Higher Premiums?

Apr 08 2019

CMS Part D Protected Class Restrictions Drawing Bipartisan Concerns In Congress

Mar 13 2019

Part B International Price Index: MedPAC Urges Focus On Enhanced Vendor Role

Jan 03 2019

Part B Reforms: MedPAC Moving Forward With 'Drug Value Program' Proposal

Mar 07 2017

Additional Topics

United States Reimbursement Legislation Pricing Debate BioPharmaceutical

More from Market Access

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window